1066 — Shandong Weigao Medical Polymer Co Balance Sheet
0.000.00%
- HK$25.66bn
- HK$22.96bn
- CNY13.09bn
- 97
- 60
- 93
- 97
Annual balance sheet for Shandong Weigao Medical Polymer Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Interim Report | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,135 | 7,133 | 6,964 | 6,989 | 8,322 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,973 | 6,142 | 7,654 | 7,717 | 8,197 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 14,367 | 16,260 | 18,288 | 18,634 | 19,443 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6,099 | 6,726 | 7,320 | 7,335 | 7,342 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 27,958 | 30,578 | 33,402 | 33,670 | 34,760 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4,598 | 5,178 | 6,005 | 7,582 | 6,081 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 9,924 | 11,171 | 11,635 | 11,221 | 11,008 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 18,034 | 19,407 | 21,767 | 22,449 | 23,752 |
Total Liabilities & Shareholders' Equity | 27,958 | 30,578 | 33,402 | 33,670 | 34,760 |
Total Common Shares Outstanding |